Skip to main content

Advertisement

Table 5 Methylation status of the TGFBI promoter in prostate cancer prostatectomy specimens with or without locoregional invasiveness

From: Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR

Locoregional invasiveness status of prostatectomy specimen Number of methylated CpG sites
  0 5–10 16
Positive (n = 18) 2 (11.1%) 9 (50.0%) 7 (38.9%)*
Negative (n = 31) 7 (22.6%) 18 (58.1%) 6 (19.4%)*
  1. *P < 0.05